Last reviewed · How we verify
Asmanex twisthaler
Asmanex twisthaler is a Small molecule drug developed by Organon and Co. It is currently FDA-approved. Also known as: Mometasone furoate inhalation powder.
At a glance
| Generic name | Asmanex twisthaler |
|---|---|
| Also known as | Mometasone furoate inhalation powder |
| Sponsor | Organon and Co |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Study of QMF149 (150/80 µg) Compared With MF Twisthaler® (200 µg) in Patients With Asthma (PHASE3)
- Individualizing Treatment for Asthma in Primary Care (PHASE4)
- A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223) (PHASE2)
- A Study of the Bronchodilator Effect of Formoterol Fumarate Used in Combination With Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P06476 AM2) (PHASE2)
- Study to Compare the Pharmacokinetics of Mometasone Furoate Alone and in Combination With Indacaterol in Patients ≥ 6 to < 12 Years Old With Asthma (PHASE2)
- Efficacy and Tolerability of Maintenance Treatment With Asmanex Twisthaler Versus Placebo in Mild/Moderate Persistent Asthmatics (Study P04654)(TERMINATED) (PHASE4)
- A Multicenter Randomized 52 Week Treatment Double-blind, Triple Dummy Parallel Group Study to Assess the Efficacy and Safety of QMF149 Compared to Mometasone Furoate in Participants With Asthma (PHASE3)
- Early Airway Response to Allergen in Asthmatics (MK-0000-176) (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Asmanex twisthaler CI brief — competitive landscape report
- Asmanex twisthaler updates RSS · CI watch RSS
- Organon and Co portfolio CI
Frequently asked questions about Asmanex twisthaler
What is Asmanex twisthaler?
Asmanex twisthaler is a Small molecule drug developed by Organon and Co.
Who makes Asmanex twisthaler?
Asmanex twisthaler is developed and marketed by Organon and Co (see full Organon and Co pipeline at /company/organon-and-co).
Is Asmanex twisthaler also known as anything else?
Asmanex twisthaler is also known as Mometasone furoate inhalation powder.
What development phase is Asmanex twisthaler in?
Asmanex twisthaler is FDA-approved (marketed).
Related
- Manufacturer: Organon and Co — full pipeline
- Also known as: Mometasone furoate inhalation powder
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing